Cargando…

Transparent reporting of adaptive clinical trials using concurrently randomised cohorts

Adaptive clinical trials have designs that evolve over time because of changes to treatments or changes to the chance that participants will receive these treatments. These changes might introduce confounding that biases crude comparisons of the treatment arms and makes the results from standard rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marschner, Ian C, Jones, Mark, Totterdell, James A, Mahar, Robert K, Snelling, Thomas L, Tong, Steven Y C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Research Methods and Reporting
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510920/ https://www.ncbi.nlm.nih.gov/pubmed/37736079 http://dx.doi.org/10.1136/bmjmed-2023-000497

Ejemplares similares

The AuTOMATIC trial: a study protocol for a multi-arm Bayesian adaptive randomised controlled trial of text messaging to improve childhood immunisation coverage
por: Currie, Grace E., et al.
Publicado: (2023)

Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule
por: Totterdell, James A., et al.
Publicado: (2022)

The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan
por: Jones, Mark A, et al.
Publicado: (2020)

Registry randomised trials: a methodological perspective
por: Doherty, Dorota A, et al.
Publicado: (2023)

Blockchain protocols in clinical trials: Transparency and traceability of consent
por: Benchoufi, Mehdi, et al.
Publicado: (2018)

OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule
por: Perez Chacon, Gladymar, et al.
Publicado: (2020)

ExplaiNN: interpretable and transparent neural networks for genomics
por: Novakovsky, Gherman, et al.
Publicado: (2023)

Rigor, Reproducibility, and Transparency in Nutrition Research Using R Dashboards
por: Baller, Daniel, et al.
Publicado: (2022)

Improving data transparency in clinical trials using blockchain smart contracts
por: Nugent, Timothy, et al.
Publicado: (2016)

ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial
por: Denholm, Justin T., et al.
Publicado: (2022)

The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
por: Dimairo, Munyaradzi, et al.
Publicado: (2020)

Reporting and transparent research practices in sports medicine and orthopaedic clinical trials: a meta-research study
por: Schulz, Robert, et al.
Publicado: (2022)

Analysis of adaptive platform trials using a network approach
por: Marschner, Ian C, et al.
Publicado: (2022)

Trial registration and time to publication in a retrospective cohort of publicly funded randomised controlled trials in New Zealand 1999–2017
por: Jull, Andrew, et al.
Publicado: (2022)

Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model® in a pharmaceutical company
por: Ducournau, Pierre, et al.
Publicado: (2019)

MEPP: more transparent motif enrichment by profiling positional correlations
por: Delos Santos, Nathaniel P, et al.
Publicado: (2022)

Role of feasibility and pilot studies in randomised controlled trials: a cross-sectional study
por: Blatch-Jones, Amanda Jane, et al.
Publicado: (2018)

Comparing the reporting and conduct quality of exercise and pharmacological randomised controlled trials: a systematic review
por: Adams, Scott C, et al.
Publicado: (2021)

Strategy for intention to treat analysis in randomised trials with missing outcome data
por: White, Ian R, et al.
Publicado: (2011)

Comparison of approaches for rational siRNA design leading to a new efficient and transparent method
por: Matveeva, Olga, et al.
Publicado: (2007)

scDesign2: a transparent simulator that generates high-fidelity single-cell gene expression count data with gene correlations captured
por: Sun, Tianyi, et al.
Publicado: (2021)

Fully integrated colorimetric sensor based on transparency substrate for salbutamol determination
por: Lomae, Atchara, et al.
Publicado: (2022)

Discontinuation and non-publication of randomised clinical trials supported by the main public funding body in Switzerland: a retrospective cohort study
por: Amstutz, Alain, et al.
Publicado: (2017)

An adaptable analysis workflow for characterization of platelet spreading and morphology
por: Pike, Jeremy A., et al.
Publicado: (2020)

Exploring redundant research into the effect of tranexamic acid on surgical bleeding: further analysis of a systematic review of randomised controlled trials
por: Ker, Katharine, et al.
Publicado: (2015)

An open and transparent process to select ELIXIR Node Services as implemented by ELIXIR-UK
por: Hancock, John M., et al.
Publicado: (2017)

Quantitative proteomic analysis reveals concurrent RNA–protein interactions and identifies new RNA-binding proteins in Saccharomyces cerevisiae
por: Klass, Daniel M., et al.
Publicado: (2013)

Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis
por: Treweek, Shaun, et al.
Publicado: (2013)

How to design efficient cluster randomised trials
por: Hemming, K, et al.
Publicado: (2017)

Towards greater transparency in neurodevelopmental disorders research: use of a proposed workflow and propensity scores to facilitate selection of matched groups
por: Bang, Janet Y., et al.
Publicado: (2020)

Selective reporting bias in randomised controlled trials from two network meta-analyses: comparison of clinical trial registrations and their respective publications
por: Wong, Eric KC, et al.
Publicado: (2019)

IGHV allele similarity clustering improves genotype inference from adaptive immune receptor repertoire sequencing data
por: Peres, Ayelet, et al.
Publicado: (2023)

Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer
por: Parpia, Sameer, et al.
Publicado: (2014)

A nested randomised trial of the effect of tranexamic acid on intracranial haemorrhage and infarction in traumatic brain injury (CRASH-3 trial intracranial bleeding mechanistic study): Statistical analysis plan
por: Mahmood, Abda, et al.
Publicado: (2019)

Discrete choice experiment to evaluate preferences of patients with cystic fibrosis among alternative treatment-related health outcomes: a protocol
por: McLeod, Charlie, et al.
Publicado: (2019)

Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data
por: Kwakkenbos, Linda, et al.
Publicado: (2018)

Integrating quantitative and qualitative data and findings when undertaking randomised controlled trials
por: Richards, David A, et al.
Publicado: (2019)

Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial
por: Roberts, Ian, et al.
Publicado: (2018)

To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials
por: Coffman, Cynthia J, et al.
Publicado: (2016)

Power estimations for non-primary outcomes in randomised clinical trials
por: Jakobsen, Janus Christian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fud6g1k92qqu37oeh14fqs0qmr